Health X Platform Ltd (HEALTHX) is currently trading at 273.65 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Health X Platform Limited (formerly Sastasundar Ventures) operates integrated healthcare platforms including RetailerShakti (B2B distribution to retailer pharmacies), SastaSundar / Healthbuddy (B2B2C franchise model) and a growing JITO private label, combining procurement, fulfilment, and technology to provide medicines and healthcare products nationally through a tech‑led, capital‑efficient model focused on affordability and last‑mile presence. Q1 FY27 showed strong operational momentum: consolidated revenue reached INR440 crore, up about 58% year‑on‑year, gross profit rose to INR34 crore with gross margin improving to 7.8%, while EBITDA losses narrowed materially to roughly INR15 crore and reported PAT was around INR2 crore, reflecting improving economics and contribution‑positive revenue streams across platforms. Health X is investing ahead of scale in technology and fulfilment: management emphasized AI investments (RetailAir), warehouse automation, and new fulfilment hubs in Noida, Guwahati, Lucknow and Udaipur, claiming the existing infrastructure plus extensions can support INR2,500–3,000 crore annual turnover, indicating a platform strategy to build capacity before demand fully materializes. The company’s growth is geographically broad and tier‑2/tier‑3 centric: RetailerShakti derives roughly 67% of sales from smaller cities and SastaSundar about 78%, and recent expansions target Odisha, Bihar, Jharkhand and the North East, which management describes as underpenetrated markets with significant upside for wallet share gains and JITO private label adoption. Key structural strengths include a short working capital cycle (~28 days, ~8% of revenue), an integrated procurement/fulfilment/tech stack, and treasury income that cushions investment; management is balancing continued investment in technology and brand with a path to improved capital efficiency and progressive profitability.

Over the past 52 weeks, Health X Platform Ltd has traded between a low of ₹252.50 and a high of ₹375.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Health X Platform Ltd has a market capitalization of approximately 870.49. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Health X Platform Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of -33.42 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 870.49 Cr, Health X Platform Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Health X Platform Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Health X Platform Ltd is -33.42. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.